Ihab Beblawi, MD
Gastroenterology · Pasadena
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 40 years
- Graduated 1986
Offices
2 locations · Genesis Healthcare Partners PC · Ridgecrest Regional Hospital
Hospitals listed: Huntington Hospital · Ridgecrest Regional Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Beblawi’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A48496 · Current
Licensed to practise in California · since 1990 · expires 2027-08-31 · Autonomous University of Guadalajara Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Huntington HospitalPasadena, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of Cedars Sinai Health System, which runs 4 hospitalsPatients rate it 3 of 5 · 76% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Ridgecrest Regional HospitalRidgecrest, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Huntington Hospital
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 1 better, 6 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.68 (0 to 1.56) · 2,225 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 149.43 (106.58 to 192.28) · 128 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.8 · 67 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 112 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.8 · 171 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 475 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.7 · 822 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 463 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 5,850 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.36) · 10,123 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.07 to 0.43) · 10,515 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.4 (2.67 to 6.13) · 2,613 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.32 (0 to 2.86) · 1,209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.77 (1.44 to 4.11) · 2,457 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.71 (1.95 to 13.48) · 1,211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.08 (0.8 to 7.36) · 1,189 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.85 (0.42 to 3.29) · 825 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.56 (0.03 to 1.09) · 8,956 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 269 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.448 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.977 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.423 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 253 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.9 · 846 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 5.2 · 176 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 20.1 · 542 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.5 · 864 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 1,144 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.2 to 8.5) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 15.2) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 260 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.1 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 201 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (8.8 to 15.8) · 365 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.6 to 1) · 786 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,430 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 76% |
| Staff "always" explained possible side effects | 41% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
See every measure and the patient survey for Ridgecrest Regional Hospital
Behind the star rating — Readmissions: 0 better, 2 the same, 0 worse of 2 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.2 (9 to 16.5) · 384 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 67 cases | No different | Jan 2024 – Dec 2024 |
Original Medicare doctor bills
$119,589
Medicare paid this office $119,589 for 438 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $12,387 | $41 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $11,644 | $147 |
| Return visit (30+ min) | 80 | $9,152 | $108 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $8,973 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $8,590 | $67 |
See all 18 services
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $12,387 | $41 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 79 | $11,644 | $147 |
| Return visit (30+ min) | 80 | $9,152 | $108 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 29 | $8,973 | $52 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $8,590 | $67 |
| Short return visit (20+ min) | 87 | $7,994 | $75 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | $7,744 | $221 |
| New patient visit (45+ min) | 56 | $7,407 | $132 |
| Biopsy of large bowel using a flexible endoscope | 45 | $6,408 | $142 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 30 | $5,707 | $190 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $5,620 | $65 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $4,252 | $213 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,151 | $189 |
| Diagnostic exam of large bowel using a flexible endoscope | 19 | $2,860 | $151 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $2,578 | $184 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $1,777 | $81 |
| New patient visit (30+ min) | 22 | $1,681 | $76 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 20 | $81 | $4 |
Procedures Medicare counted
| Colonoscopy | 109 | More than 82% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 165 | More than 87% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 47 | 29 | 50 | 68 | 85 | 87 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | 23 | 35 | 31 | 43 | 35 |
| Biopsy of large bowel using a flexible endoscope | 25 | 21 | 26 | 35 | 28 | 45 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | 14 | 26 | 16 | 14 | 22 |
| Diagnostic exam of large bowel using a flexible endoscope | – | – | 16 | 12 | 12 | 19 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | 11 | – | 16 | – | 14 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
438 Original Medicare patients in 2024. Average age 75 · Under 65 5% · 85 and older 11% · Women 52% · Also on Medicaid 32% · Health risk score 1.67. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Coronary heart disease 43% · Diabetes 41% · Depression 29% · Chronic kidney disease 27% · Heart failure 26% · Atrial fibrillation 22% · COPD 19% · Cancer 18% · Dementia 13% · Stroke 13%.
The office billed $713,544, Medicare allowed $151,607 and paid $119,589; for 1,385 services of 52 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 438 | 1,385 | 75 | 1.67 | $713,544 | $119,589 |
| 2023 | 393 | 1,221 | 75 | 1.74 | $600,611 | $103,153 |
| 2022 | 381 | 1,198 | 75 | 1.55 | $423,051 | $100,729 |
| 2021 | 339 | 1,344 | 75 | 1.75 | $322,526 | $99,005 |
| 2020 | 271 | 667 | 74 | 1.81 | $211,707 | $62,645 |
| 2019 | 297 | 653 | 75 | 1.68 | $168,388 | $66,437 |
| 2018 | 372 | 864 | 75 | 1.71 | $217,763 | $84,285 |
| 2017 | 341 | 798 | 74 | 1.75 | $186,565 | $72,012 |
| 2016 | 340 | 668 | 74 | 1.68 | $187,698 | $74,447 |
| 2015 | 336 | 694 | 75 | 1.89 | $202,973 | $79,595 |
| 2014 | 358 | 752 | 75 | 1.73 | $232,176 | $88,780 |
| 2013 | 331 | 712 | 76 | 1.91 | $247,555 | $78,407 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 76 | $11,182 | $142 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 22 | $10,225 | $40 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 43 | $9,431 | $219 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 94 | $9,347 | $65 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 21 | $7,921 | $52 |
| Short return visit (20+ min) | 87 | $7,478 | $69 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $6,664 | $78 |
| New patient visit (45+ min) | 41 | $5,275 | $129 |
| Return visit (30+ min) | 48 | $5,063 | $99 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 26 | $4,840 | $186 |
| Biopsy of large bowel using a flexible endoscope | 28 | $3,810 | $136 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $3,805 | $173 |
| New patient visit (30+ min) | 29 | $2,354 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,680 | $140 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,281 | $91 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 19 | $63 | $3 |
2022: 18 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 68 | $11,531 | $167 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 26 | $10,418 | $41 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 27 | $8,789 | $52 |
| Return visit (30+ min) | 64 | $7,699 | $103 |
| Short return visit (20+ min) | 88 | $7,397 | $70 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 69 | $7,278 | $60 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 30 | $6,706 | $216 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 67 | $4,838 | $71 |
| Biopsy of large bowel using a flexible endoscope | 35 | $4,241 | $121 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $4,036 | $192 |
| New patient visit (45+ min) | 31 | $3,882 | $125 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $3,600 | $180 |
| New patient visit (30+ min) | 44 | $3,431 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,034 | $190 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $3,013 | $188 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,760 | $147 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,305 | $82 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 14 | $50 | $3 |
2021: 20 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 74 | $13,020 | $171 |
| Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | 35 | $11,319 | $33 |
| Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | 34 | $8,296 | $35 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 35 | $7,708 | $220 |
| Short return visit (20+ min) | 79 | $7,700 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 74 | $7,684 | $61 |
| New patient visit (30+ min) | 53 | $4,184 | $79 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $3,905 | $78 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 17 | $3,416 | $201 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,320 | $195 |
| Biopsy of large bowel using a flexible endoscope | 26 | $3,116 | $120 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,336 | $146 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 25 | $2,228 | $86 |
| New patient visit (45+ min) | 13 | $1,626 | $125 |
| Insertion of guide wire with dilation of esophagus using a flexible endoscope | 11 | $1,415 | $118 |
| Return visit (30+ min) | 14 | $1,414 | $101 |
| Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $1,150 | $72 |
| Telephone medical discussion with physician, 11-20 minutes | 13 | $976 | $75 |
| Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | 12 | $588 | $37 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $37 | $3 |
2020: 15 services
| Short return visit (20+ min) | 95 | $8,701 | $59 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,331 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 63 | $6,951 | $62 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $5,219 | $227 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,537 | $197 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 15 | $2,992 | $199 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,519 | $229 |
| Biopsy of large bowel using a flexible endoscope | 21 | $2,256 | $107 |
| New patient visit (30+ min) | 30 | $2,131 | $71 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 29 | $2,067 | $71 |
| Return visit (30+ min) | 30 | $2,059 | $66 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $1,944 | $177 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,156 | $83 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $497 | $41 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $43 | $3 |
2019: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,179 | $167 |
| Short return visit (20+ min) | 97 | $7,540 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $6,022 | $61 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 27 | $5,976 | $221 |
| Return visit (30+ min) | 53 | $5,490 | $81 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 22 | $4,366 | $198 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $4,066 | $87 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 16 | $3,253 | $191 |
| Biopsy of large bowel using a flexible endoscope | 25 | $3,119 | $125 |
| New patient visit (45+ min) | 21 | $2,694 | $128 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,397 | $200 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $1,583 | $88 |
| New patient visit (30+ min) | 23 | $1,482 | $64 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 13 | $47 | $4 |
2018: 15 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $12,181 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 76 | $9,428 | $61 |
| Short return visit (20+ min) | 107 | $8,339 | $54 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $6,326 | $218 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $5,144 | $78 |
| New patient visit (30+ min) | 66 | $4,983 | $76 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 25 | $4,761 | $190 |
| Return visit (30+ min) | 50 | $4,730 | $88 |
| Biopsy of large bowel using a flexible endoscope | 33 | $4,500 | $136 |
| New patient visit (45+ min) | 32 | $3,785 | $118 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,448 | $203 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,385 | $154 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $2,282 | $190 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,028 | $79 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 30 | $98 | $3 |
2017: 16 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 78 | $10,043 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 55 | $9,684 | $167 |
| Short return visit (20+ min) | 114 | $9,246 | $56 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 26 | $5,569 | $214 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 24 | $4,886 | $204 |
| New patient visit (30+ min) | 60 | $4,839 | $81 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 46 | $3,420 | $73 |
| Biopsy of large bowel using a flexible endoscope | 25 | $2,956 | $118 |
| Return visit (30+ min) | 31 | $2,804 | $85 |
| Diagnostic exam of large bowel using a flexible endoscope | 18 | $2,649 | $139 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,335 | $195 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,108 | $176 |
| New patient visit (45+ min) | 16 | $1,842 | $115 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 16 | $1,149 | $72 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 23 | $182 | $8 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 36 | $141 | $4 |
2016: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 70 | $11,581 | $165 |
| Short return visit (20+ min) | 95 | $7,334 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 70 | $6,779 | $61 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 23 | $4,926 | $205 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 21 | $4,818 | $219 |
| New patient visit (30+ min) | 56 | $4,766 | $85 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 50 | $4,608 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 21 | $4,524 | $215 |
| Biopsy of large bowel using a flexible endoscope | 26 | $3,634 | $140 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 16 | $3,349 | $209 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,845 | $168 |
| Return visit (30+ min) | 20 | $1,741 | $87 |
| New patient visit (45+ min) | 11 | $1,561 | $142 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $679 | $57 |
2015: 13 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 73 | $12,643 | $171 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $8,734 | $250 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 79 | $8,362 | $61 |
| Short return visit (20+ min) | 89 | $6,742 | $56 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $5,192 | $108 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 22 | $4,922 | $224 |
| New patient visit (30+ min) | 58 | $4,324 | $75 |
| Biopsy of large bowel using a flexible endoscope | 28 | $3,951 | $141 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,670 | $223 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,588 | $173 |
| New patient visit (45+ min) | 19 | $2,540 | $134 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 20 | $1,786 | $89 |
| Return visit (30+ min) | 20 | $1,774 | $84 |
2014: 14 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 80 | $13,576 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $7,659 | $59 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 29 | $7,516 | $259 |
| Biopsy of large bowel using a flexible endoscope | 34 | $6,040 | $178 |
| Short return visit (20+ min) | 75 | $5,822 | $58 |
| New patient visit (45+ min) | 39 | $5,254 | $135 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 54 | $4,588 | $82 |
| New patient visit (30+ min) | 57 | $4,517 | $79 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 20 | $4,259 | $213 |
| Diagnostic exam of large bowel using a flexible endoscope | 20 | $3,489 | $159 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $3,388 | $199 |
| Return visit (30+ min) | 34 | $3,218 | $89 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,760 | $230 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $2,293 | $96 |
2013: 17 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 92 | $15,068 | $162 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 91 | $9,314 | $56 |
| Ultrasound guided needle aspiration or biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $7,040 | $352 |
| Short return visit (20+ min) | 76 | $5,205 | $53 |
| Biopsy of large bowel using a flexible endoscope | 27 | $4,742 | $176 |
| New patient visit (30+ min) | 50 | $4,085 | $82 |
| Ultrasound exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 18 | $3,941 | $219 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 17 | $3,839 | $226 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 41 | $3,574 | $81 |
| Diagnostic exam of large bowel using a flexible endoscope | 21 | $3,266 | $156 |
| New patient visit (45+ min) | 21 | $2,842 | $135 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,696 | $225 |
| Colorectal cancer screening; colonoscopy on individual at high risk | 12 | $2,607 | $217 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $2,190 | $100 |
| Return visit (30+ min) | 24 | $2,133 | $89 |
| New patient visit (15+ min) | 18 | $958 | $53 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $599 | $32 |
Drugs they prescribed that Part D paid
$160,138
Pharmacies billed $160,138 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
504 generic and 88 brand-name prescriptions · $160,138 in drug cost · 47 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Omeprazole | 159 | $1,812 | $11 |
| Pantoprazole | 65 | $1,061 | $16 |
| Famotidine | 98 | $1,048 | $11 |
| Dicyclomine | 19 | $300 | $16 |
| Azathioprine | 12 | $299 | $25 |
See all 9 drugs
| Omeprazole | 159 | $1,812 | $11 |
| Pantoprazole | 65 | $1,061 | $16 |
| Famotidine | 98 | $1,048 | $11 |
| Dicyclomine | 19 | $300 | $16 |
| Azathioprine | 12 | $299 | $25 |
| Peg 3350-Electrolyte | 13 | $295 | $23 |
| Gavilyte-G | 12 | $164 | $14 |
| Amitriptyline | 12 | $128 | $11 |
| Metronidazole | 12 | $85 | $7 |
Year by year
| 2024 | 592 | 218 | None | 15% | $160,138 |
| 2023 | 589 | 185 | 0% (0) | None | $218,360 |
| 2022 | 576 | 190 | None | 7% | $91,508 |
| 2021 | 594 | 185 | None | 11% | $169,052 |
| 2020 | 640 | 190 | None | 14% | $107,304 |
| 2019 | 626 | 227 | 0% (0) | 10% | $100,651 |
| 2018 | 942 | 462 | 0% (0) | 17% | $72,384 |
| 2017 | 959 | 568 | None | 30% | $74,438 |
| 2016 | 896 | 561 | None | None | $93,382 |
| 2015 | 975 | 566 | None | 35% | $83,252 |
| 2014 | 971 | 594 | None | 43% | $148,986 |
| 2013 | 480 | 213 | 0% (0) | 36% | $48,712 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 9 drugs
| Budesonide Er | 18 | $21,823 | $1,212 |
| Linzess | 16 | $9,106 | $569 |
| Omeprazole | 191 | $2,860 | $15 |
| Famotidine | 56 | $1,225 | $22 |
| Pantoprazole | 78 | $1,153 | $15 |
| Dicyclomine | 22 | $385 | $17 |
| Propranolol | 12 | $275 | $23 |
| Metoclopramide | 11 | $141 | $13 |
| Metronidazole | 11 | $111 | $10 |
2022: 12 drugs
| Mesalamine | 31 | $17,070 | $551 |
| Linzess | 11 | $5,797 | $527 |
| Cholestyramine | 15 | $3,326 | $222 |
| Omeprazole | 151 | $1,968 | $13 |
| Pantoprazole | 85 | $1,447 | $17 |
| Famotidine | 58 | $1,139 | $20 |
| Ondansetron | 14 | $519 | $37 |
| Dicyclomine | 27 | $504 | $19 |
| Ciprofloxacin | 17 | $253 | $15 |
| Metronidazole | 15 | $229 | $15 |
| Amitriptyline | 14 | $139 | $10 |
| Metoclopramide | 17 | $111 | $7 |
2021: 12 drugs
| Humira | 11 | $69,332 | $6,303 |
| Mesalamine | 24 | $21,094 | $879 |
| Budesonide Er | 16 | $14,761 | $923 |
| Linzess | 19 | $10,399 | $547 |
| Omeprazole | 156 | $2,311 | $15 |
| Pantoprazole | 93 | $1,421 | $15 |
| Famotidine | 34 | $832 | $24 |
| Dicyclomine | 29 | $671 | $23 |
| Ondansetron | 11 | $225 | $20 |
| Metronidazole | 14 | $213 | $15 |
| Amitriptyline | 17 | $140 | $8 |
| Metoclopramide | 20 | $118 | $6 |
2020: 15 drugs
| Creon | 15 | $19,625 | $1,308 |
| Linzess | 20 | $9,905 | $495 |
| Mesalamine | 17 | $9,571 | $563 |
| Cholestyramine | 22 | $4,982 | $226 |
| Omeprazole | 171 | $2,394 | $14 |
| Pantoprazole | 78 | $1,128 | $14 |
| Dicyclomine | 39 | $634 | $16 |
| Ondansetron | 11 | $400 | $36 |
| Esomeprazole Magnesium | 17 | $399 | $23 |
| Prednisone | 16 | $327 | $20 |
| Lansoprazole | 12 | $294 | $25 |
| Amitriptyline | 25 | $251 | $10 |
| Metronidazole | 14 | $167 | $12 |
| Famotidine | 15 | $160 | $11 |
| Metoclopramide | 17 | $150 | $9 |
2019: 15 drugs
| Cholestyramine | 26 | $5,074 | $195 |
| Omeprazole | 148 | $2,370 | $16 |
| Pantoprazole | 87 | $1,180 | $14 |
| Esomeprazole Magnesium | 19 | $994 | $52 |
| Mercaptopurine | 12 | $532 | $44 |
| Clarithromycin | 11 | $476 | $43 |
| Dicyclomine | 31 | $425 | $14 |
| Propranolol | 19 | $413 | $22 |
| Peg 3350-Electrolyte | 18 | $304 | $17 |
| Metronidazole | 18 | $260 | $14 |
| Gavilyte-G | 19 | $237 | $12 |
| Amitriptyline | 20 | $219 | $11 |
| Ranitidine | 15 | $214 | $14 |
| Gavilyte-N | 12 | $160 | $13 |
| Furosemide | 16 | $53 | $3 |
2018: 20 drugs
| Dexilant | 11 | $5,936 | $540 |
| Omeprazole | 202 | $3,222 | $16 |
| Lansoprazole | 12 | $2,267 | $189 |
| Cholestyramine | 14 | $2,255 | $161 |
| Sulfasalazine Dr | 25 | $1,367 | $55 |
| Peg 3350-Electrolyte | 78 | $1,258 | $16 |
| Esomeprazole Magnesium | 13 | $1,243 | $96 |
| Gavilyte-G | 97 | $1,141 | $12 |
| Gavilyte-N | 58 | $983 | $17 |
| Pantoprazole | 69 | $692 | $10 |
| Propranolol | 28 | $565 | $20 |
| Ciprofloxacin | 12 | $468 | $39 |
| Peg-3350 and Electrolytes | 40 | $457 | $11 |
| Gavilyte-C | 26 | $315 | $12 |
| Dicyclomine | 23 | $280 | $12 |
| Metronidazole | 16 | $246 | $15 |
| Ranitidine | 15 | $222 | $15 |
| Ondansetron | 14 | $189 | $14 |
| Polyethylene Glycol 3350 | 11 | $187 | $17 |
| Amitriptyline | 16 | $92 | $6 |
2017: 18 drugs
| Creon | 15 | $13,660 | $911 |
| Nexium | 16 | $5,506 | $344 |
| Esomeprazole Magnesium | 17 | $2,436 | $143 |
| Omeprazole | 156 | $2,296 | $15 |
| Gavilyte-N | 117 | $1,999 | $17 |
| Peg 3350-Electrolyte | 117 | $1,577 | $13 |
| Gavilyte-G | 99 | $1,267 | $13 |
| Peg-3350 and Electrolytes | 85 | $1,051 | $12 |
| Pantoprazole | 64 | $792 | $12 |
| Erythromycin | 11 | $708 | $64 |
| Loperamide | 11 | $295 | $27 |
| Gavilyte-C | 24 | $290 | $12 |
| Polyethylene Glycol 3350 | 12 | $204 | $17 |
| Ranitidine | 25 | $196 | $8 |
| Metronidazole | 14 | $194 | $14 |
| Amitriptyline | 13 | $164 | $13 |
| Dicyclomine | 14 | $146 | $10 |
| Famotidine | 16 | $107 | $7 |
2016: 13 drugs
| Creon | 24 | $22,481 | $937 |
| Nexium | 30 | $12,406 | $414 |
| Lialda | 11 | $10,805 | $982 |
| Erythromycin | 20 | $3,025 | $151 |
| Gavilyte-N | 142 | $2,395 | $17 |
| Peg 3350-Electrolyte | 118 | $1,865 | $16 |
| Omeprazole | 95 | $1,472 | $15 |
| Peg-3350 and Electrolytes | 79 | $999 | $13 |
| Pantoprazole | 70 | $995 | $14 |
| Gavilyte-G | 67 | $927 | $14 |
| Gavilyte-C | 46 | $508 | $11 |
| Ranitidine | 26 | $217 | $8 |
| Famotidine | 13 | $108 | $8 |
2015: 17 drugs
| Creon | 19 | $17,121 | $901 |
| Dexilant | 12 | $3,548 | $296 |
| Peg 3350-Electrolyte | 141 | $2,481 | $18 |
| Gavilyte-N | 123 | $2,238 | $18 |
| Erythromycin | 11 | $2,232 | $203 |
| Pantoprazole | 123 | $1,607 | $13 |
| Mercaptopurine | 14 | $1,590 | $114 |
| Lansoprazole | 26 | $1,572 | $60 |
| Omeprazole | 88 | $1,412 | $16 |
| Peg-3350 and Electrolytes | 91 | $1,211 | $13 |
| Gavilyte-G | 68 | $933 | $14 |
| Sulfasalazine | 13 | $394 | $30 |
| Gavilyte-C | 27 | $328 | $12 |
| Neomycin Sulfate | 12 | $253 | $21 |
| Ranitidine | 33 | $237 | $7 |
| Metronidazole | 11 | $151 | $14 |
| Ciprofloxacin | 11 | $88 | $8 |
2014: 17 drugs
| Humira | 13 | $71,112 | $5,470 |
| Asacol Hd | 13 | $11,004 | $846 |
| Nexium | 23 | $8,645 | $376 |
| Gavilyte-N | 151 | $2,842 | $19 |
| Peg-3350 | 162 | $2,799 | $17 |
| Dexilant | 15 | $2,749 | $183 |
| Lansoprazole | 30 | $1,914 | $64 |
| Pantoprazole | 91 | $1,400 | $15 |
| Peg-3350 and Electrolytes | 95 | $1,340 | $14 |
| Omeprazole | 84 | $1,238 | $15 |
| Mercaptopurine | 24 | $1,221 | $51 |
| Gavilyte-G | 39 | $580 | $15 |
| Loperamide | 12 | $454 | $38 |
| Gavilyte-C | 35 | $406 | $12 |
| Sulfasalazine | 14 | $396 | $28 |
| Ranitidine | 18 | $217 | $12 |
| Peg 3350-Electrolyte | 19 | $207 | $11 |
2013: 12 drugs
| Nexium | 20 | $4,760 | $238 |
| Dexilant | 11 | $1,758 | $160 |
| Pantoprazole | 91 | $1,522 | $17 |
| Lansoprazole | 19 | $1,312 | $69 |
| Omeprazole | 71 | $1,193 | $17 |
| Mercaptopurine | 12 | $1,064 | $89 |
| Sulfasalazine | 19 | $791 | $42 |
| Peg-3350 With Flavor Packs | 30 | $550 | $18 |
| Peg-3350 and Electrolytes | 28 | $419 | $15 |
| Gavilyte-N | 22 | $339 | $15 |
| Gavilyte-C | 14 | $196 | $14 |
| Peg 3350-Electrolyte | 12 | $139 | $12 |
Money from drug and device companies
$1,337 in 2025
| 2025 | 8 | 37 | None | $1,337 |
| 2024 | 8 | 47 | None | $1,051 |
| 2023 | 11 | 46 | None | $1,026 |
| 2022 | 6 | 58 | None | $1,206 |
| 2021 | 6 | 44 | None | $1,000 |
| 2020 | 6 | 14 | None | $285 |
| 2019 | 11 | 41 | None | $831 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Rinvoq | $442 | 24 payments
|
| Madrigal Pharmaceuticals | Rezdiffra | $389 | 3 payments
|
| Boston Scientific | General - Therapies | $160 | 2 payments
|
| Ardelyx | Ibsrela | $125 | 1 payment
|
| Lilly USA | Omvoh | $106 | 1 payment
|
| Janssen Biotech | Tremfya | $72 | 4 payments
|
See all 37 published payments
| Abbvie | Meals · 2025-12-16 | Skyrizi | $23 |
| Abbvie | Meals · 2025-12-15 | Rinvoq | $4 |
| Abbvie | Meals · 2025-12-15 | Rinvoq | $8 |
| Abbvie | Meals · 2025-11-18 | Skyrizi | $17 |
| Abbvie | Meals · 2025-11-18 | Rinvoq | $3 |
| Madrigal Pharmaceuticals | Meals · 2025-11-18 | Rezdiffra | $145 |
| Abbvie | Meals · 2025-11-06 | Rinvoq | $15 |
| Abbvie | Meals · 2025-11-06 | Rinvoq | $17 |
| Abbvie | Meals · 2025-10-27 | Rinvoq | $4 |
| Abbvie | Meals · 2025-10-27 | Rinvoq | $11 |
| Abbvie | Meals · 2025-09-09 | Rinvoq | $15 |
| Abbvie | Meals · 2025-08-30 | Rinvoq | $12 |
| Abbvie | Meals · 2025-08-19 | Rinvoq | $13 |
| Ardelyx | Meals · 2025-08-13 | Ibsrela | $125 |
| Madrigal Pharmaceuticals | Meals · 2025-08-12 | Rezdiffra | $123 |
| Abbvie | Meals · 2025-08-09 | Rinvoq | $1 |
| Abbvie | Meals · 2025-08-08 | Rinvoq | $13 |
| Abbvie | Meals · 2025-07-31 | Rinvoq | $18 |
| Abbvie | Meals · 2025-07-19 | Linzess | $34 |
| Janssen Biotech | Meals · 2025-07-10 | Tremfya | $16 |
| Boston Scientific | Meals · 2025-06-17 | General - Therapies | $137 |
| Celltrion USA | Meals · 2025-06-05 | Vegzelma | $15 |
| Abbvie | Meals · 2025-05-31 | Rinvoq | $13 |
| Abbvie | Meals · 2025-05-07 | Rinvoq | $17 |
| Janssen Biotech | Meals · 2025-04-25 | Tremfya | $17 |
| Janssen Biotech | Meals · 2025-04-16 | Tremfya | $20 |
| Lilly USA | Meals · 2025-04-09 | Omvoh | $106 |
| Madrigal Pharmaceuticals | Meals · 2025-03-18 | Rezdiffra | $121 |
| Boston Scientific | Meals · 2025-03-17 | General - Biliary Devices | $23 |
| Abbvie | Meals · 2025-03-17 | Rinvoq | $27 |
| Abbvie | Meals · 2025-02-27 | Skyrizi | $20 |
| Abbvie | Meals · 2025-02-20 | Rinvoq | $13 |
| Abbvie | Meals · 2025-02-06 | Rinvoq | $16 |
| Abbvie | Meals · 2025-02-06 | Skyrizi | $125 |
| Janssen Biotech | Meals · 2025-02-04 | Tremfya | $18 |
| Abbvie | Meals · 2025-01-30 | Creon | $4 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-01-21 | Entyvio | $28 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $1,051
| Abbvie | Rinvoq | $580 | 31 payments
|
| Celltrion USA | Zymfentra | $196 | 4 payments
|
| Aimmune Therapeutics | Vowst | $89 | 3 payments
|
| Janssen Biotech | Stelara | $68 | 4 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $36 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Cyltezo | $35 | 1 payment
|
| Ipsen Biopharmaceuticals | Iqirvo | $25 | 1 payment
|
| Merck Sharp & Dohme | Dificid | $22 | 1 payment
|
2023: $1,026
| AbbVie | Rinvoq | $597 | 30 payments
|
| Apollo Endosurgery US | Overstitch Endoscopic Suturing System | $139 | 1 payment
|
| QOL Medical | Sucraid | $56 | 2 payments
|
| Janssen Biotech | Stelara | $48 | 3 payments
|
| Pfizer | Xeljanz | $42 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $40 | 2 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $33 | 2 payments
|
| Intercept Pharmaceuticals | Ocaliva | $21 | 1 payment
|
| Celgene | Zeposia | $17 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
| Nestle Healthcare Nutrition | Vowst | $15 | 1 payment
|
2022: $1,206
| Abbvie | Rinvoq | $1,015 | 48 payments
|
| QOL Medical | Sucraid | $57 | 3 payments
|
| Janssen Biotech | Stelara | $50 | 3 payments
|
| Pfizer | Xeljanz | $42 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $24 | 1 payment
|
| Lucid Diagnostics | None | $17 | 1 payment
|
2021: $1,000
| AbbVie | Humira | $744 | 36 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $136 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $36 | 2 payments
|
| RedHill Biopharma | Movantik | $32 | 2 payments
|
| Pfizer | Xeljanz | $27 | 1 payment
|
| Ironwood Pharmaceuticals | Linzess | $25 | 1 payment
|
2020: $285
| AbbVie | Humira | $100 | 6 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $71 | 3 payments
|
| Takeda Pharmaceuticals U.S.A. | Motegrity | $37 | 2 payments
|
| Shionogi | Mulpleta | $28 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $25 | 1 payment
|
| Janssen Biotech | Stelara | $24 | 1 payment
|
2019: $831
| AbbVie | Humira | $190 | 19 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $154 | 7 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $95 | 4 payments
|
| Mauna Kea Technologies | None | $88 | 2 payments
|
| Endogastric Solutions | Esophyx | $80 | 1 payment
|
| Erbe USA | Erbe | $74 | 1 payment
|
| Covidien LP | Beacon | $65 | 2 payments
|
| Gilead Sciences | None | $30 | 2 payments
|
| Allergan | Zenpep | $20 | 1 payment
|
| Pfizer | Xeljanz | $20 | 1 payment
|
| QOL Medical | Sucraid | $15 | 1 payment
|
Professional record
- NPI
- 1942272075
- Licence
- CA A48496California A48496: Current · expires 2027-08-31
- Group
- Genesis Healthcare Partners PC · Ridgecrest Regional Hospital
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 50 Alessandro Pl, Suite 410, Pasadena, CA, 91105
- NPI first listed
- 2006-02-02
- NPI last updated
- 2016-11-30
This is when the NPI record was last certified, not a medical board exam.